Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sofibel, incorporating Laboratoires Fumouze, is a prominent French healthcare company specializing in over-the-counter (OTC) products and medical diagnostics. As a subsidiary of Church & Dwight since 2006, the company manages a portfolio of well-known brands, most notably Stérimar, a global leader in sea water-based nasal hygiene products. The company's diagnostic division, Fumouze Diagnostics, provides rapid testing solutions for infectious diseases and clinical pathology. Sofibel focuses on the development, manufacturing, and distribution of health and hygiene products across European and international markets. Its operations are centered in France, where it maintains significant manufacturing and R&D capabilities for its core brands.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sofibel Laboratoires Fumouze.